Stay updated on Combination Immunotherapy in Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the Combination Immunotherapy in Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Combination Immunotherapy in Prostate Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Added Prostate cancer and related topics including MedlinePlus Genetics, and updated Revision from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-18T22:57:04.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision: v3.4.3 added; Prostate cancer, related topics, MedlinePlus Genetics, and Revision: v3.4.2 removed.
    Difference
    0.1%
    Check dated 2026-03-11T18:26:36.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Added related topics Prostate cancer and MedlinePlus Genetics to the page's related topics section; this provides extra context for readers without changing the trial details.
    Difference
    0.1%
    Check dated 2026-03-04T14:28:43.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    40 days ago
    Change Detected
    Summary
    Addition: Revision: v3.4.2 is shown, and older Revision: v3.4.1 references and Prostate cancer topic links were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T11:16:59.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a government funding notice banner with links to cc.nih.gov and opm.gov, plus related Prostate Cancer topic links and a revision note (v3.4.1); the previous revision entry (v3.4.0) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-04T06:52:54.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    Added long-term outcome definitions (rPFS, TTR-PCWG3, DOR-PCWG3, TTP-PSA) with timeframes up to 84 months and related metric descriptions. Introduced Brazil locations (Rio de Janeiro and São Paulo) with addresses and a 'Show glossary' option on the page.
    Difference
    2%
    Check dated 2026-01-28T04:53:32.000Z thumbnail image

Stay in the know with updates to Combination Immunotherapy in Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Combination Immunotherapy in Prostate Cancer Clinical Trial page.